International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Oncol Lett 10: [Related article:] 77-84, 2015; DOI: 10.3892/ol.2015.3242
Subsequently to the publication of the above paper, it has been brought to the attention of the Editor that there were a number of striking similarities between the article and another paper published in a different journal by different authors located at different research institutions. First, numerous textual similarities were noted between several paragraphs of the text comparing between this paper and the other paper, which was published in Oncology Reports, also in 2015: Wang R-H, Cao H-M, Tian Z-J, Jin B, Wang Q, Ma H and Wu J: Efficacy of dual-functional liposomes containing paclitaxel for treatment of lung cancer. Oncol Rep 33: 783–791, 2015. Furthermore, Fig. 9 in the above article contained data plots that were also strikingly similar to those included in Fig. 9 in the paper published in Oncology Reports.
After having considered these aspects, the Editor of Oncology Letters has decided that the above paper should be retracted from the publication on the grounds of a lack of certainty regarding the independence and integrity of the study. The authors were contacted in this regard, but did not offer any rebuttal in light of the Editor's decision to retract this paper. Note that the study by Wang et al in Oncology Reports has also been retracted. The Editor regrets any inconvenience that this retraction has caused.